CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department
Critical Care2011Vol. 15(3), pp. R157–R157
Citations Over TimeTop 12% of 2011 papers
W. Frank Peacock, Joseph Varón, Brigitte M. Baumann, Pierre Borczuk, Chad Cannon, Abhinav Chandra, David Cline, Deborah B. Diercks, Brian Hiestand, Amy P. Hsu, P. Jois-Bilowich, Brian Kaminski, Philip Levy, Richard M. Nowak, Jon W. Schrock
Abstract
Patients treated with nicardipine are more likely to reach the physician-specified SBP target range within 30 minutes than those treated with labetalol.
Related Papers
- → CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department(2011)61 cited
- → Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients(2017)17 cited
- Nicardipine vs labetalol in treating acute and severe hypertension(2001)
- Nicardipine and labetalol in controlling hypertension during laparoscopic cholecystectomy(2004)
- Labetalol vs.Nicardipine for Hypertension in Patients with Acute Aortic Dissection(2007)